EU Health Programmes

Transcription

1 Evaluation of the Health Programme and Future actions under the new Health Programme Michael Hübel Health Programme Management and Diseases DG Health and Consumers European Commission EP Health Working Group Workshop "Prevention and Healthy Life" EU Health Programmes AIDS Prevention & communicable diseases Injury prevention Drug prevention Health monitoring Cancer Rare diseases Pollution related diseases Community action programme in the field of health EUR 312 million 2 nd Community action programme in the field of health EUR 321,5 million 3 rd Union action programme in the field of health EUR 449,4 million Health Promotion, Information, Education & training 1

2 Evaluating the 2 nd Health Programme Legal obligation (Art. Article 13 (3)(c) of Dec. No 1350/2007/EC ) Mid-term evaluation ( ) For the reports of evaluations and audits see at Ex-post evaluation to be conducted in 2014 The timeframe The scope of the ex-post evaluation to assess the Programme as a whole building upon earlier evaluation work 2

3 Ex-post evaluation of the HP Questions around four main objectives to be assessed MANAGEMENT TOOLS Financial mechanisms Technical assistance Creation of nomenclature for EU added value, the scientific evidence, etc. Simplification and rationalisation of the procedures DISSEMINATION PRACTICES Results published and disseminated in a sustainable way Health Programme Database Publications Dissemination activities for overcoming possible geographical imbalances The role of stakeholders Improvement in dissemination practices to increase return on investment SYNERGIES WITH OTHER SERVICES & PROGRAMMES European Structural and Cohesion Funds other Programmes (in particular those managed by EMPL, CNECT) COM general objectives-focus on Europe 2020 related to social policy and economic growth THE IMPACT the relevance of the Programme actions vis-à-vis the Union mandate in health and to the short-term and mid-term progress achieved in specific areas. Methodological considerations Desk research Interviews INTERVENTION LOGIC PARTNERSHIP STRATEGIES Database searches Survey Cost-benefit analysis Bibliometric studies Screening of health policy areas Case studies CAUSALITY FACTORS 3

4 3 rd Health Programme : scope and objectives Encouraging innovation in health Protecting citizens from serious crossborder health threats Promoting health Support MS to improve the health of EU citizens and reduce health inequalities Increasing the sustainability of health systems 1) Promote health, prevent disease and foster supportive environments for healthy lifestyles 2) Protect citizens from serious cross-border health threats 3) Contribute to innovative, efficient and sustainable health systems 4) Facilitate access to better and safer healthcare for Union citizens Budget for : million e 1) Promoting health, preventing diseases and fostering supportive environments for healthy lifestyles Cost-effective promotion and prevention measures for addressing tobacco, alcohol, unhealthy dietary habits, physical inactivity Chronic diseases including cancer; good practices for prevention, early detection and management, including self-management HIV/AIDS, TB and hepatitis; up-take of good practices for cost- effective prevention, diagnosis, treatment and care Legislation on tobacco products advertisement and marketing Health information and knowledge system 4

5 2) Protecting citizens from serious Ooperation w cross-border health threats Legislation in the fields of communicable diseases and other health threats (Health Security Initiative) Improve risk assessment by providing additional capacities for scientific expertise and map existing assessments Support capacity building, cooperation with neighbouring countries, preparedness planning, non-binding approaches on vaccination, joint procurement 3) Contributing to innovative, efficient and sustainable health systems pertise Health Technology Assessment Up-take of health innovation and e-health solutions Health workforce forecasting and planning (number, scope of practice, skills), mobility/migration of health professionals Mechanism for pooled expertise and good practices assisting Member States in their health systems reforms Health in an ageing society, including European Innovation Partnership on Active and Healthy Ageing Legislation in the field of medical devices, medicinal products and cross-border healthcare Health information and knowledge system including Scientific Committees 5

6 4) Facilitating access to better and safer healthcare Medical device for EU citizens European Reference Networks (on the basis of criteria to be set under Directive 2011/24/EU) Rare diseases (networks, databases and registries) Patient safety and quality of healthcare including the prevention and control of healthcare-associated infections Antimicrobial resistance Legislation in the field of tissues and cells, blood, organs, medical devises, medicinal products, and patients rights in cross-border healthcare Health information and knowledge system New Annex II Criteria for establishing annual work programmes Policy Relevance EU added value Public health relevance Support to implementation of legislation Pertinence of geographical coverage Balanced distribution of resources between objectives Adequate coverage of thematic priorities 6

7 Focus on thematic priorities Example: Risk Factors and Chronic Diseases Annual work programme - Consultation of Member States (via Programme Committee) and Parliament - Consideration of suggestions by stakeholders - EP involvement as well as through Annual implementation reports Mid-term review (June 2017) Ex-post Programme evaluations Parliamentary questions 7

8 Thank you! 15 8